ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

ClinicalTrials.gov ID: NCT01785849

Public ClinicalTrials.gov record NCT01785849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis

Study identification

NCT ID
NCT01785849
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
508 participants

Conditions and interventions

Interventions

  • Etelcalcetide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 11, 2013
Primary completion
May 21, 2014
Completion
Jun 11, 2014
Last update posted
Aug 25, 2019

2013 – 2014

United States locations

U.S. sites
51
U.S. states
19
U.S. cities
47
Facility City State ZIP Site status
Research Site Birmingham Alabama 35211
Research Site Pine Bluff Arkansas 71603
Research Site Azusa California 91702
Research Site Covina California 91723
Research Site Lakewood California 90712
Research Site Los Angeles California 90025
Research Site Lynwood California 90262
Research Site Northridge California 91324
Research Site Ontario California 91762
Research Site Panorama City California 91402
Research Site Sacramento California 95825
Research Site Whittier California 90603
Research Site Pembroke Pines Florida 33028
Research Site Meridian Idaho 83642
Research Site Evanston Illinois 60201
Research Site Springfield Massachusetts 01107
Research Site Detroit Michigan 48236
Research Site Kalamazoo Michigan 49007
Research Site Pontiac Michigan 48341
Research Site Southgate Michigan 48195
Research Site Tupelo Mississippi 38801
Research Site Kansas City Missouri 64111
Research Site Reno Nevada 89511
Research Site Amherst New York 14226
Research Site Brooklyn New York 11235
Research Site Rosedale New York 11422
Research Site The Bronx New York 10461
Research Site Yonkers New York 10704
Research Site Chapel Hill North Carolina 27599
Research Site Durham North Carolina 27704
Research Site Allentown Pennsylvania 18104
Research Site Philadelphia Pennsylvania 19106
Research Site Philadelphia Pennsylvania 19118
Research Site Orangeburg South Carolina 29118
Research Site Sumter South Carolina 29150
Research Site Columbia Tennessee 38401
Research Site Nashville Tennessee 37205
Research Site Austin Texas 78758
Research Site Fort Worth Texas 76105
Research Site Fort Worth Texas 76164
Research Site Grand Prairie Texas 75050
Research Site Houston Texas 77030
Research Site Mansfield Texas 76063
Research Site San Antonio Texas 78205
Research Site San Antonio Texas 78215
Research Site San Antonio Texas 78229
Research Site Tyler Texas 75701
Research Site Fairfax Virginia 22033
Research Site Mechanicsville Virginia 23116
Research Site Norfolk Virginia 23502
Research Site Bluefield West Virginia 24701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01785849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2019 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01785849 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →